E-LIB Suche - Ergebnisse für: Frias, Juan Pablo

1

Tirzepatide in Hispanic/Latino Patients With Type 2 Diabete..:

Frías, Juan Pablo ; Galindo, Rodolfo J ; Wang, Hui...
The Journal of Clinical Endocrinology & Metabolism. 109 (2023) 2 - p. 557-568 , 2023

Link: https://doi.org/10.1210/..

2

FRI183 Phase 4 Study Of Hypercortisolism In Patients With D..:

Frias, Juan Pablo ; Auchus, Richard Joseph ; Bancos, Irina...
Journal of the Endocrine Society. 7 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1210/..

3

Efficacy and safety of once‐weekly efpeglenatide in people ..:

Aroda, Vanita R. ; Frias, Juan Pablo ; Ji, Linong...
Diabetes, Obesity and Metabolism. 25 (2023) 8 - p. 2084-2095 , 2023

Link: https://doi.org/10.1111/..

4

Obesity among Latinx people in the United States: A review:

Alemán, José Orlando ; Almandoz, Jaime P. ; Frias, Juan Pablo.
Obesity. 31 (2023) 2 - p. 329-337 , 2023

Link: https://doi.org/10.1002/..

5

BIO89-100 Demonstrated Robust Reductions in Liver Fat, Impr..:

Frias, Juan Pablo ; Ortiz-Lasanta, Grisell ; Hartsfield, Cynthia L....
Metabolism. 128 (2022) - p. 155016 , 2022

Link: https://doi.org/10.1016/..

6

Efficacy of Dulaglutide Expanded Doses by Baseline A1C Cate..:

Frias, Juan Pablo ; Bonora, Enzo ; Cox, David A...
Journal of the Endocrine Society. 5 (2021) Supplement_1 - p. A332-A333 , 2021

Link: https://doi.org/10.1210/..

7

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious ..:

Frias, Juan Pablo ; Chien, Jenny ; Zhang, Qianyi...
Journal of the Endocrine Society. 5 (2021) Supplement_1 - p. A448-A449 , 2021

Link: https://doi.org/10.1210/..

8

BIO89-100 Demonstrated Robust Reductions in Liver Fat and L..:

Frias, Juan Pablo ; Lawitz, Eric J ; Ortiz-LaSanta, Grisell...
Journal of the Endocrine Society. 5 (2021) Supplement_1 - p. A5-A6 , 2021

Link: https://doi.org/10.1210/..

9

Efficacy and safety of adding sotagliflozin, a dual sodium‐..:

Danne, Thomas ; Edelman, Steven ; Frias, Juan Pablo...
Diabetes, Obesity and Metabolism. 23 (2020) 3 - p. 854-860 , 2020

Link: https://doi.org/10.1111/..

10

The SYDNEY Device Study: A Multicenter, Randomized, Open-la..:

Frias, Juan Pablo ; Koren, Michael J. ; Loizeau, Virginie...
Clinical Therapeutics. 42 (2020) 1 - p. 94-107.e5 , 2020

Link: https://doi.org/10.1016/..

11

Efficacy and tolerability of tirzepatide, a dual glucose‐de..:

Frias, Juan Pablo ; Nauck, Michael A. ; Van, Joanna...
Diabetes, Obesity and Metabolism. 22 (2020) 6 - p. 938-946 , 2020

Link: https://doi.org/10.1111/..

12

OR26-08 Efficacy and Safety of Higher Dulaglutide Doses (3...:

Cox, David A ; Woodward, Brad ; Milicevic, Zvonko...
Journal of the Endocrine Society. 4 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1210/..

13

Impact of disease duration and β‐cell reserve on the effica..:

Del Prato, Stefano ; Frias, Juan Pablo ; Blonde, Lawrence...
Diabetes, Obesity and Metabolism. 22 (2020) 9 - p. 1567-1576 , 2020

Link: https://doi.org/10.1111/..

14

Efficacy and safety of the second generation basal insulin ..:

Vargas-Uricoechea, Hernando ; Frias, Juan Pablo
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 13 (2019) 3 - p. 1975-1989 , 2019

Link: https://doi.org/10.1016/..

15

Efficacy and safety of insulin glargine/lixisenatide (iGlar..:

Handelsman, Yehuda ; Chovanes, Christina ; Dex, Terry...
Journal of Diabetes and its Complications. 33 (2019) 3 - p. 236-242 , 2019

Link: https://doi.org/10.1016/..